Alkem Laboratories Ltd (ALKE.NS)
22 Jun 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- India's Alkem Labs gets USFDA report about Amaliya unit
- BRIEF-Alkem Laboratories Gets Form 483 With 13 Observations After U.S. FDA Inspection At Co's Amaliya Facility
- BRIEF-India's Alkem Laboratories Dec Qtr Consol Profit Falls
- BRIEF-Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility
- BRIEF-India's Alkem Laboratories Gets Shareholders' Nod For Appointment Of Sandeep Singh As MD